A Study of LY900014 in a Medtronic Pump

I8B-MC-ITSM -

The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog)when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes(T1D). The study will consist of two treatment periods of 4 weeks.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
Insulin Lispro, LY900014
Could I receive a Placebo?
No
Enrollment Goal
42
Trial Dates
Feb 18, 2019 - Oct 7, 2019
How long will I be in the trial?
The study will last about 13 weeks and may include up to 6 live visits and 5 phone visits.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.